KT5720
KT5720 structure
|
Common Name | KT5720 | ||
|---|---|---|---|---|
| CAS Number | 108068-98-0 | Molecular Weight | 537.60600 | |
| Density | 1.49g/cm3 | Boiling Point | 715ºC at 760mmHg | |
| Molecular Formula | C32H31N3O5 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 386.2ºC | |
Use of KT5720KT5720 is a cell-permeable, potent, specific, reversible, ATP-competitive inhibitor of protein kinase A (PKA), with a Ki of 60 nM[1][2]. |
| Name | kt 5720 |
|---|---|
| Synonym | More Synonyms |
| Description | KT5720 is a cell-permeable, potent, specific, reversible, ATP-competitive inhibitor of protein kinase A (PKA), with a Ki of 60 nM[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 60 nM (PKA)[1][2]. |
| References |
| Density | 1.49g/cm3 |
|---|---|
| Boiling Point | 715ºC at 760mmHg |
| Molecular Formula | C32H31N3O5 |
| Molecular Weight | 537.60600 |
| Flash Point | 386.2ºC |
| Exact Mass | 537.22600 |
| PSA | 94.72000 |
| LogP | 5.93440 |
| Vapour Pressure | 1.88E-21mmHg at 25°C |
| Index of Refraction | 1.752 |
|
Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2.
Biochem. Pharmacol. 96 , 306-14, (2015) Metastasis is the major cause of death in cancer patients. Elevated expression of cyclooxygenase-2 (COX-2) is observed in many human cancers and over-production of downstream prostaglandins (PGs) has ... |
|
|
Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells.
Am. J. Physiol. Cell Physiol. 299 , C516-27, (2010) The signaling mechanisms underlying cell differentiation have been extensively studied with the use of rat PC12 cells as a model system. Nerve growth factor (NGF) is a trophic factor inducing PC12 cel... |
|
|
Prostaglandin potentiates 5-HT responses in stomach and ileum innervating visceral afferent sensory neurons.
Biochem. Biophys. Res. Commun. 456(1) , 167-72, (2015) Gastrointestinal disorder is a common symptom induced by diverse pathophysiological conditions that include food tolerance, chemotherapy, and irradiation for therapy. Prostaglandin E2 (PGE2) level inc... |
| MFCD00132118 |